Amplia Therapeutics Limited
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply![Get A$10 trading credit to start you off](/images/content-cards/reward_content_card.png)
About ATX
Amplia Therapeutics Limited (ATX) is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in cancer and Amplia has a particular development focus in fibrotic tumours such as pancreatic and ovarian cancers. FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
Buy Australian shares starting with ATX. Invest today with a CHESS-sponsored investing platform!
Sector
Health Care
CEO
Dr John Lambert
Industry
Biotechnology
Website
ampliatx.com
$24M
-4.31
-
$0.14
$0.09
$0.12
$0.14
$0.06
Announcements
Ready to start your investing journey with Stake?
Open an accountATX FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in ATX
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ATX
on Stake
Buy ATX from AU$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
![Canstar award phone](/_next/image?url=%2Fimages%2Fstocks%2Fsidebar_phone_4x.png&w=3840&q=75)